Summary
This phenome-wide Mendelian randomization study examined how circulating protein levels causally influence susceptibility to complex diseases, integrating data from large-scale genome-wide association studies and protein quantitative trait loci. The approach used genetic variants as instrumental variables to infer causal relationships whilst accounting for confounding and reverse causation, providing evidence-grounded candidates for therapeutic intervention. The findings suggest that plasma proteomics may identify modifiable intermediate pathways linking genetic risk to disease manifestation.
UK applicability
The study's international cohort design and genetic instrumental variable approach are broadly generalisable to UK populations of European ancestry. Findings may inform future clinical biomarker development and personalised disease prevention strategies in UK healthcare settings, though population-specific validation would strengthen translation.
Key measures
Causal effect estimates (odds ratios, log odds) of plasma proteins on disease outcomes; statistical significance thresholds and multiple testing correction; bidirectional analyses to detect reverse causation
Outcomes reported
The study used Mendelian randomization to map causal associations between plasma protein levels and risk of complex diseases across multiple phenotypes. This approach leveraged genetic variants as instrumental variables to infer protein–disease relationships.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.